Indeed, the engagement of OX40, a costimulatory molecule expressed primarily on activated CD4+ T cells, induces tumor-specific CD4+ T cell population able to eradicate advanced melanomas in mice and also human melanoma cells in an in vitro model. This evidence concerns the gene TNFRSF4 and melanoma.